Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
By Country
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Home
»
Analysts
»
Matthew Dellatorre
Matthew Dellatorre
Follow
Stock Analyst at Goldman Sachs
(4.69)
# 771
Out of 5,040 analysts
14
Total ratings
100%
Success rate
60.9%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - Specialty & Generic
Stocks Rated by Matthew Dellatorre
Stock
Action
Price Target
Current
Upside
Ratings
Updated
AMRX
Amneal Pharmaceuticals
Reiterated:
Buy
$21
$19.65
+6.87%
10
Aug 10, 2026
VTRS
Viatris
Reiterated:
Hold
$10
→
$12
$17.44
-31.19%
4
Oct 22, 2025
AMRX
Amneal Pharmaceuticals
Aug 10, 2026
Reiterated:
Buy
Price Target:
$21
Current: $19.65
Upside:
+6.87%
10 Ratings
View All
VTRS
Viatris
Oct 22, 2025
Reiterated:
Hold
Price Target:
$10
→
$12
Current: $17.44
Upside:
-31.19%
4 Ratings
View All